Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A six-year retrospective study

Pharmacological Research

Volumn 46, Issue 5, 2002, Pages 395-400

  Gallelli, L ^a   Ferreri, G ^a   Colosimo, M ^a   Pirritano, D ^a   Guadagnino, L ^a   Pelaia, G ^a   Maselli, R ^a   De Sarro, G B ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Policlinico Mater Domini   (Italy)

Author keywords

Adverse drug reactions; Antibiotics; Clinical records; Hospitalised patients; Pulmonology

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BROMHEXINE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE FOSFATEX; ERYTHROMYCIN; IMIPENEM; METHYLPREDNISOLONE; OFLOXACIN; PENICILLIN G; PIPERACILLIN; SULBACTAM; SULFAMETHOXYPYRIDAZINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANEMIA; ANGINA PECTORIS; ANTIBIOTIC THERAPY; ARTICLE; BRONCHODILATATION; CARDIOVASCULAR DISEASE; CHILD; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG SURVEILLANCE PROGRAM; DYSPNEA; EDEMA; FAINTNESS; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HEART ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HOSPITALIZATION; HUMAN; HYPOTENSION; INFANT; ITALY; LETHARGY; LEUKOPENIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PRIORITY JOURNAL; PRURITUS; PSORIASIS; RASH; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN TOXICITY; STEVENS JOHNSON SYNDROME; TACHYCARDIA; THROMBOCYTOPENIA; VERTIGO; VOMITING; DRUG UTILIZATION; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; MIDDLE AGED; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES;

EID: 0036435711     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043661802002104     Document Type: Article

References (30)

1. Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, Royer RJ. Adverse drug reaction monitoring: Doing it the French way. Lancet 1985; 2: 1056-8.
2. Lee CE, Zembower TR, Fotis MA, Postelnick MJ, Greenberger PA, Peterson LR, Noskin GA. The incidence of antimicrobial allergies in hospitalised patients: Implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med 2000; 160: 2819-22.
3. Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J. Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol 2001; 56: 935-41.
4. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalised patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1977; 277: 301-6.
5. Lindquist R, Gersema LM. Understanding and preventing adverse drug reaction. AACN Clin Issues 1998; 9: 119-28.
6. Pilzer JD, Burke TG, Mutnick AH. Drug allergy assessment at an university hospital and clinic. Am J Health Syst Pharm 1996; 53: 2970-5.
7. Rawlins MD. Spontaneous reporting of adverse drug reactions: I. The data. Br J Clin Pharmacol 1988; 26: 7-11.
8. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions. JAMA 1999; 281: 824-9.
9. Novotny J, Novotny M. Adverse drug reactions to antibiotics and major antibiotic drug interactions. Gen Physiol Biophys 1999; 18: 126-39.
10. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA 1979; 242: 623-32.
11. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247-54.
12. Colt HG, Shapiro AP. Drug-induced illness as a cause for admission to a community hospital. J Am Geriatr Soc 1989; 37: 323-6.
13. Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalised medical patients? J Am Geriatr Soc 1991; 39: 1093-9.
14. Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, Damsbo N. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83-90.
15. Hutchinson TA, Leventhal JM, Kramer MS, Karch FE, Lipman AG, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. JAMA 1979; 242: 633-8.
16. Morales-Olivas FJ, Martinez-Mir I, Ferrer JM, Rubio E, Palop V. Adverse drug reactions in children reported by means of the yellow card in Spain. J Clin Epidemiol 2000; 53: 1076-80.
17. Lemozit JP, Petit De La Rhodier G, Lapeyre-Mestre M, Bagheri H, Montastruc L. A comparative study of adverse drug reactions reported through hospital and private medicine. Br J Clin Pharmacol 1996; 41: 166-8.
18. Kraaij van DJW, Haagsma CJ, Go IH et al. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Neth J Med 1994; 44: 166-73.
19. Mannesse CK, Derkx FH, De Ridder MAJ, In T, Veld M, van der Cammen TJM. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35-9.
20. Veehof LJ, Stewart RE, Meyboom-de Jong B, Haaijer-Ruskamp F. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999; 55: 533-6.
21. Beyth RJ, Shorr RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging 1999; 14: 231-9.
22. Da Fonseca MA. Adverse reaction to amoxicillin: A case report. Pediatr Dent 2000; 22: 401-4.
23. Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics (clinical conference). Ann Intern Med 1987; 107: 204-15.
24. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001; 53: 357-79.
25. Hutchinson TA, Flegel KM, Kramer MS, Leduc DG, Kong HH. Frequency, severity and risk factors for adverse drug reactions in adult out-patients: a prospective study. J Chronic Dis 1986; 39: 533-42.
26. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137: 765-70.
27. Chosidow O. Drug-induced exanthemas. Rev Prat 2000; 50: 1310-3.
28. Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJM, Aronson JK, Grahame-Smith DG. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicine. Br J Clin Pharmacol 1996; 42: 423-9.
29. Helsby NA, Ward SA, Parslew RA, Friedmann PS, Rhodes LE. Hepatic cytochrome P450 CYP2C activity in psoriasis: studies using proguanil as a probe compound. Acta Derm Venereol 1998; 78: 81-3.
30. Roberts J, Tumer N. Pharmacodynamic basis for altered drug action in the elderly. Clin Geriatr Med 1988; 4: 127-49.